Life Science Company News

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

Read more ››
By: GlobeNewswire - 30 Apr 2024

SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure

Read more ››
By: GlobeNewswire - 30 Apr 2024

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Read more ››
By: GlobeNewswire - 30 Apr 2024

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Read more ››
By: GlobeNewswire - 30 Apr 2024

Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)

Read more ››
By: GlobeNewswire - 30 Apr 2024

Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia

Read more ››
By: GlobeNewswire - 30 Apr 2024

ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer

Read more ››
By: GlobeNewswire - 30 Apr 2024

Nacuity Pharmaceuticals Announces First Patients Implanted in Final Cohort of Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Read more ››
By: GlobeNewswire - 30 Apr 2024

Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders

Read more ››
By: GlobeNewswire - 30 Apr 2024

Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers

Read more ››
By: GlobeNewswire - 30 Apr 2024

Kamari Pharma Appoints Dr. John Doux to its Board of Directors

Read more ››
By: GlobeNewswire - 30 Apr 2024

WeightWatchers Hosts ‘Making The Shift: A New Way to Think About Weight,’ A Live Virtual Event with Oprah Winfrey on Thursday, May 9

Read more ››
By: GlobeNewswire - 30 Apr 2024

Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients

Read more ››
By: GlobeNewswire - 30 Apr 2024

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand

Read more ››
By: GlobeNewswire - 30 Apr 2024

Resolutions of Annual Geneal Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024

RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine

Read more ››
By: GlobeNewswire - 30 Apr 2024

Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases

Read more ››
By: GlobeNewswire - 30 Apr 2024

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

Read more ››
By: GlobeNewswire - 30 Apr 2024
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate